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a b S T r a C T
This paper examines psychiatric diagnosis-making within biomedicine, as 
studies in this field, especially empirical ones, have attracted little attention 
throughout the scientific world. The widely accepted assertion, that diag-
nosis is the result of clinical judgement, will be discussed. Through analysis 
of a case study conducted in a Barcelona hospital, it will be suggested that 
psychiatric diagnosis is not only the result of clinical assessment, but also of 
psychotropic drugs translation. Drawing on actor-network theory and the 
notion of boundary objects established by Star and Griesemer (1989), it is 
therefore proposed that psychotropic drugs are boundary objects which act 
as central mediators in knowledge management, setting up the semiotic-
material assemblage of diagnosis.
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r e S u m e n
El presente artículo examina la producción del diagnóstico psiquiátrico en 
biomedicina, debido a que los estudios, especialmente los empíricos en este 
campo, han atraído poco la atención de los investigadores. La afirmación 
ampliamente aceptada de que el diagnóstico es el resultado de un juicio 
clínico, será discutida. A través de un estudio de caso llevado a cabo en un 
hospital de Barcelona, propondremos que el diagnóstico psiquiátrico no es 
unicamente el resultado de un juicio clínico, sino también de una traducción 
psicofarmacológica. Haciendo uso de la teoría del actor-red y de la noción 
de objetos frontera desarrollada por Star y Griesemer (1989), sostenemos 
que los psicofármacos como objetos frontera actúan como los mediadores 
centrales en la gestión del conocimiento, estableciendo el ensamblaje 
semiótico-material del diagnóstico.
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Introduction
According to Joanna Moncrieff, the concept of 
diagnosis in psychiatry entails an equality between 
psychiatric classification and the process of medical 
diagnosis with the entailment that psychiatric prob-
lems are originated by a physical dysfunction (2010). 
However, researchers have been unable to identify 
an underlying physical process in psychiatric disor-
ders since the inception of the field; diagnosis there-
fore remains a controversial issue. Several studies 
have described the complexity and fragmentation 
of diagnosis in medicine (Blaxter, 1978; Bowker & 
Star 1999; Mol, 2002). Many endeavors have been 
made to overcome the vulnerability of diagno-
sis in medical practice. Evidence-based-medicine 
attempts to address the heterogeneous situation 
integrating in clinical settings the best available 
clinical evidence (Sacket, Rosenberg, Gray, Haynes, 
& Richardson, 1992). However, these attempts 
to strengthen the scientific approach of medical 
practice have not succeeded in eliminating the 
uncertainty that has characterized the practice of 
psychiatry from its outset. This handicap is more 
visible in psychiatry than in other medical fields, 
prompting a clinical discourse about the definition 
of diagnosis. During the current research, we have 
observed a general agreement that psychiatric di-
agnosis is the result of clinical judgement, despite 
the different approaches among psychiatrists. This 
widely accepted and pivotal statement shapes, as 
a matter of fact, psychiatric discourse in both the 
medical and biomedical field. Within this discourse, 
however, little attention has been paid to the trans-
formations that medicine has experienced over the 
last two decades, particularly the epistemic change 
of medicine becoming biomedicine (Keating & 
Cambrosio, 2003). The neologism biomedicine 
refers to the reduction of medicine to a branch 
of biology in which the genomic sciences are the 
most important purveyors in this rearrangement 
(Cambrosio, Keating, Schlich, & Weisz, 2006). In 
this biomedical domain hardly exist any empirical 
studies of psychiatric diagnosis, and approaches 
which consider the procedure of diagnosis-making 
itself are scarce.
Considering this background, our objective was 
to examine how a psychiatric diagnosis is produced, 
that means, which material elements are form-
ing it, from the Actor Network Theory (ANT) 
perspective. The extent to which the subject of 
psychotropic drugs arose during the ethnography 
and fieldwork discussions, identifying them as the 
key actors in psychiatric routines, prompted us to 
specify our research and examine their importance. 
Thus, we focussed on the psychotropic drugs’s work 
in the diagnosis-making process. Other possible 
influential issues like diagnostic categories or the 
psychiatrist-patient relationship, are not considered 
in this analysis and might be subject matter of fur-
ther research.
After discussing social science studies of diag-
nosis, we illustrate the conceptual theoretical tools 
used for analysis. Then interview data and focused 
ethnography (Knoblauch, 2005) conducted in a 
Barcelona hospital during 2012-2013 to analyze 
diagnosis-making are presented. Subsequently we 
discuss how a diagnosis results from the recom-
mendations for psychotropic drugs, or through 
psychotropic drugs translation. In order to describe 
this process, the notion of boundary objects as es-
tablished by Star & Griesemer (1989) is applied. We 
put forward that psychotropic drugs as boundary 
objects support the ambiguity und uncertainty of 
psychiatric practices in the process of diagnosis-
making in its own materiality. Finally we discuss 
the influence of psychotropic drugs within the 
diagnosis-making process in biomedicine.
The social study of psychiatric diagnosis
Critical social literature has largely approached psy-
chiatric diagnosis through the medicalization pro-
cess of clinical medicine (Conrad, 1975, 1979, 1992, 
2007; Conrad & Schneider, 1980; Scott, 2006; 
Szasz, 2007). In this context, the social sciences 
have focused on the importance of the diagnosis, 
subsuming it within the broader process of social 
control termed medicalization. Medicalization and 
diagnosis are indeed closely connected; however the 
concepts belong to different explanatory domains. 
One of the means through which medicalization 
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functions is the labeling of deviant social behaviour 
with a diagnosis (Zola, 1972). However, medicaliza-
tion forms a wider framework for medicine to oper-
ate within, accentuates its values and underlines its 
authoritative role (Jutel, 2009). Diagnoses are the 
classification tools of medicine, forming one of the 
main entities through which the power of medicine 
operates (Jutel, 2009). An important body of litera-
ture in relation to diagnosis has been developed 
in the field of medical sociology. Many studies in 
this arena have highlighted the consequences and 
inflictions that diagnosis produce to people´ s lives 
(Jutel, 2008; Horwitz, 2011). The implications of an 
absence of diagnosis in situations where a disorder 
has been alleged to exist have also been examined 
such as the well-known account of Post-Traumatic 
Stress Disorder for incorporation into DSM III1 
(Scott, 1990). When disease applications have not 
successfully gained recognition, the possibility of 
assigning political responsibility is denied (Trundle, 
2011). Furthermore, it is claimed that diagnoses pro-
vide relief for chronic illness sufferers by validating 
their physical suffering (Lillrank, 2003), and pro-
mote the process of collective identity through the 
political potential of challenging professional au-
thority and assigned identity (Brown & Zavetovsky 
2004). Finally, diagnosis may confer recognition on 
patients, removing them from the isolation of their 
suffering and providing them with further support 
(Chong, 2001, quoted in Jutel 2009). However, 
other studies have addressed the ambivalence in a 
diagnostic label, by reporting the narratives of chil-
dren diagnosed with ADHD2 (Singh, 2011). This 
collection of works concerning the effects of diag-
nosis illustrates how the diagnosis itself can claim 
or blame, legitimize or stigmatize, facilitate access to 
resources or restrain opportunities (Jutel & Nettle-
ton, 2011). It is also worth highlighting works from 
the anti-psychiatry standpoint, which contend that 
psychiatric diagnosis constitutes the imposition of 
value judgements derived from a custodial ideology 
established to defend society rather than care for 
the ill (Cooper, 1974; Basaglia, 1972; Basaglia, & 
1 Diagnostic Statistical Manual of Mental Disorders III edition.
2  Attention Deficit Hyperactive Disorder.
Carrino, 1975). At the same time, psychiatric diag-
noses have been understood as the articulation of 
changes in the concept of normal and pathological 
in different societies over time. The archeology of 
psychiatric power which Foucault (2003) carried 
out, emphasizes how psychiatric diagnosis as a dis-
cursive practice derives from the dispositif of power. 
Moreover, the social construction of diagnosis has 
been illustrated in studies which underline how a 
particular condition is firstly described in medical 
terms and then incorporated into the category of 
disease (Goode, 1969; Conrad & Schneider 1980; 
Brown, 1995). This notion of the social construc-
tion of diagnosis has recently been discussed with 
reference to the work of Mol, postulating the fragil-
ity of diagnosis and diseases that become enacted in 
different medical assemblages (Mol, 2002; Gardner, 
Dew, Stubbe, Dowell, & Macdonald, 2011). Finally 
Jackie Orr (2010) reports about informatic man-
agement of psychiatric diagnosis as a key element 
of governmentality and contemporary psychiatry.
Theoretical background: Translation 
and Boundary Objects
The notion of translation developed by the ANT 
is used in the analysis in order to account for the 
diagnosis-making process. According to Latour 
(2001), translation means displacement, deriva-
tion, invention, and can be understood as one of 
the meanings of the mediation: the translation 
of goals. Translation means the process by which 
some actors are awarded and/or given the power to 
act on behalf of others (Latour, 1998). To translate 
is “to express in one´ s own language what others 
say and want, why they act in the way they do and 
how they associate with each other: it is to establish 
oneself as a spokesman” (Callon, 1986, pp. 18-19). 
More precisely, in this analysis translation refers 
to the work of psychotropic drugs as producers of 
diagnostic entities.
Discussing this concept, particularly the idea of 
obligatory passage point being enacted by transla-
tion process, Star & Griesemer created boundary 
objects notion. Boundary objects are abstract or 
concrete, flexible enough to adapt to local needs 
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and robust enough to maintain a common identity 
across worlds, taking part in collecting, managing 
and coordinating distributed knowledge (Star & 
Griesemer 1989; Trompette & Vinck, 2009). The 
notion is used to describe how actors coordinate 
and negotiate the different meanings of the objects 
while maintaining their autonomy and communica-
tion (Star & Griesemer, 1989). Boundary objects 
allow different groups to collaborate without con-
sensus (Star, 2010). The boundary objects theory 
gives an account of how a dispositif articulates the 
distributed and heterogeneous perspective of work 
and collective action.
Nevertheless the boundary objects collective 
model differs in two aspects from the translation 
analytical model of ANT (Fujimura, 1992). Firstly, 
the boundary objects notion allows translation to 
take place without the preeminence of one actor. 
Secondly, both analytical dispositifs are interested 
in the mechanism of associations, but only the 
boundary objects notion focuses on the way asso-
ciations support the tension between cooperation 
and heterogeneity (Fujimura, 1992).
This theoretical perspective should be able 
to provoke a necessary radical comprehension of 
the facts to generate political projects and create 
novel explanations to relieve the suffering of users 
of mental services. Like Foucault (2003) asserts, 
psychiatry from the beginning dealt more with the 
segregation of the subjects than with the creation 
of truth about madness.
Data and methods
The research presented in this paper is based on a 
case study conducted between July 2012 and July 
2013. A series of qualitative non-standardized in-
depth interviews and a focused ethnography (Kno-
blauch, 2005) were carried out in three phases: a) 
first round of four interviews, b) focused ethnog-
raphy in a Short Stay Unit of Psychiatry, c) second 
round of five interviews. Nine members of the 
psychiatry service at a University Hospital in Bar-
celona were interviewed face-to-face, among them 
seven psychiatrists, a psychologist and a biologist. 
The interviewees worked in the three service areas 
the hospital runs for the care of psychiatric disor-
ders: Outpatient Care Programs, the Laboratory for 
Genetic Analysis, and the Short Stay Unit of Psy-
chiatry. Four of the psychiatrists were men, among 
them three chairmen of the Programs, while three 
were women, one the chairwoman of the Short Stay 
Unit. The biologist, a woman, worked in the Ge-
netic Analysis Laboratory doing biological research 
in connection with a psychiatric program. The 
psychologist, also a woman, worked in a psychiatric 
program. Each interview followed a script posing 
open-ended questions, lasted between 40 and 60 
minutes, took place in the hospital area and was 
recorded and transcribed. The subjects broached 
were as follows: how they grounded their decisions; 
the kind of technologies (tools, medical exams, pro-
cedures, protocols) used in clinical routines in order 
to support their judgements; how important neu-
roimaging studies were in the diagnostic process; 
whether the use of technologies enabled exchanges 
with other clinicians and how this was carried out; 
their opinions about the increasing rate of diagno-
ses and the medicalisation of everyday life. While 
the first round of interviews was more open ex-
amining the diagnosis-making in general, we nar-
rowed the focus in the second round of interviews, 
as a result of the previouly collected ethnographic 
data. Thus we concentrated on the role, uses and 
significances of psychotropic drugs in psychiatric 
practices. The Short Stay Unit, where the focused 
ethnography was carried out in October/ Novem-
ber 2012, is intended to receive those patients 
from the Emergency Unit who give indications of 
disorder or psychiatric disturbance in the clinical 
encounters. A psychiatry team provides short-term 
care and examination, in order to quickly recover 
the basal behavior and stabilize the patient, either 
for discharge or transfer to a psychiatric center for 
long-term care. Further data were obtained from 
daily informal exchanges with two psychiatrists at 
the Unit, accompanying them at patient interviews 
and observing their daily activities, which con-
sisted of conversations with the nurse team, calls 
and interviews with patient’s families, discussions 
and coordination with other health professionals 
and social workers, permanently registering their 
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activities by computer and consulting data in the 
patients records. A content and qualitative analysis 
(Ruiz Olabuénaga, 2003) of the textual material 
of interviews was conducted. The theoretical per-
spective has been the core of the analysis, being 
itself theoretical-interpretive. The selected data 
were inferred from a recursive process between the 
narratives of interviews and the research question, 
their significance interpreted with the context and 
theoretical background taken into account. The 
ethnographic field-notes were analyzed follow-
ing the thick description method (Geertz, 1987), 
focusing on the statements made by psychiatrists 
related to diagnosis and on the diagnosis-making 
process itself.
Analysis: Psychiatric diagnosis 
and psychotropic drugs: the 
management of uncertainty
This is an excerpt from a field-note transcribing an 
interview between a psychiatrist and a patient’s son. 
Extract Nº 1:
Ernesto’s son: What is it, is it dementia?
Psychiatrist: Cognitive impairment as a result of the 
vascular accident, had a stroke in 2005.
...
Ernesto’s son: But what is the 
diagnosis, what does my father have?
Psychiatrist: At the age of 50 it is difficult, as it 
may be an outbreak, there are different types of 
schizophrenia (Field-note 22 October 2012, author´ s 
translation).
After the interview we talk about Ernesto in the 
medical room. The psychiatrist and the neurologist 
discuss whether the OCD3 has compulsive hoarding 
behavior or if it is due to cognitive impairment. They 
value that yes, that no, that it might be in this case, 
then they suddenly change to another topic. They 
look at the patient’s EEG4, and interpret it properly 
(Field-note, further discussion in medical ward be-
3 Obsessive-compulsive disorder.
4 Electroencephalogram.
tween psychiatrist and neurologist 22 October 2012, 
author’s translation).
These fragments underscore the uncertainty 
that frequently characterizes the clinical psychiatric 
judgement. The high degree of indeterminacy of 
clinical situations makes it possible and feasible to 
diagnose a cognitive impairment, OCD or schizo-
phrenia to an individual at the same moment of 
his biography. In this case the diagnosis is made 
following the DSM s´ mainstream literature, so that 
it is possible to overlap diagnoses, because they are 
defined by an addition of symptoms. However, this 
situation is not perceived as problematic. On the 
contrary, as part of the normal routines, the psy-
chiatrists deal with the ambiguity. In the current 
biomedical context and perhaps due to the lower 
degree of development and stabilization of scien-
tific knowledge within psychiatry (Rabeharisoa 
& Bourret, 2009), a surprising situation has been 
observed in the following conversation in a medical 
ward, Extract Nº 2:
When the son went away I ask the psychiatrist 
what she believes about Ernesto, I tell her his son 
mentioned a previous diagnosis, and if he suffered 
from a psychiatric disease before, the stroke would 
alter the picture. Her reply to me was the same as 
to the son: that it is not likely for schizophrenia to 
appear at the age of 49/50, but it also may just be an 
outbreak. These data do not seem to be relevant for 
a medical decision. What really matters is the se-
lected medication, quetiapine, and how the patient 
is responding to it. (Field-note 22 October 2012, 
author’s translation).
This case shows that there exist situations where 
psychopharmacological use occurs prior to diag-
nostic assessment in psychiatric clinical routines. 
As a way to organize medical activities in order to 
manage the problems the illness poses, psychotropic 
drugs are administered before a diagnosis is made. 
Thus, the classical formula “judgement - diagnosis 
- treatment”, characteristic of clinical medicine, 
is not observed in the analyzed context. On the 
contrary, the diagnosis seems to be made after 
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psychotropic drugs recommendations and usage, 
being the product of the patient’s response to pre-
scribed psychotropic drugs. As we can notice in the 
following extract taken from a conversation with a 
psychiatrist in the medical ward at the Short Stay 
Unit, Extract Nº 3:
[…] the ideal initial action is to deliver medication 
to a patient and examine him/her later. If someone 
does not cooperate, is restless, cannot be controlled, 
you deliver medication not to sedate but to calm him 
down, ease the anxiety and dysphoria and examine 
him/her later (conversation with psychiatrist Irina, 
Field-note, 13 November 2012, author’s translation).
As we can see, the patient` s evaluation starts 
with an observation of an individual who has been 
administered psychotropic substances previously. 
This medical action aims to recover the health of 
the patient and functions in practices like the first 
support in order to make a diagnosis. Indeed the 
psychiatric evaluation deals from the beginning 
with an amount of data where the clinical signs 
are intertwined with the significances produced by 
clinical collectives5 embodied in the psychophar-
macological drugs. For this reason, the questions 
concerning psychopharmacology require an impor-
tant place in the interviews, Extract Nº 4:
The psychiatrist interviews María in her patient 
room:
P: How do you feel?
M: A little bit anxious.
P: How did you sleep?
M: I would have needed a pill more for the anxiety, 
but finally it´ s gone.
P: What about your mood...?
M: I think it´ s better, but I feel like a pudding.
P: How does the medication work?
M: Better...
5  They are formed by the laboratories, groups of researchers and 
doctors who develop guidelines, clinical consortia composed by 
biologists, statisticians, and experts in the life sciences.
P: It took much time to decide the correct medica-
tion in order to get you to sleep, and control your 
anxiety.
The exploration of the body effects after admin-
istering psychotropic drugs is an important piece of 
thread to obtain knowledge about the patient´ s con-
dition. This examination focused on psychotropic 
drugs provides crucial information, and the patient, 
the “linguistic voice” (Leder, 2016), expresses the 
effects of the body. But why do the psychiatrists 
prioritize the data coming from the body effects 
translated by the patient´ s narrative?
At first, because there exists neither a body to 
be examined nor diagnostic technologies to be ap-
plied. This distinctive characteristic of psychiatric 
diagnosis creates the special positioning for the 
psychotropic drugs. They become the only reliable 
resource of data, apart from clinical hermeneutic, 
in order to ground or to support the clinical judge-
ment. For this reason, the psychotropic substances 
are available in order to be used before, during and 
after the diagnosis-making process, being an impor-
tant support to get information about the state of a 
patient´ s mental health.
Second, it is as a matter of fact, due to historical 
reasons that the psychotropic drugs exist prior to 
diagnostic clinical evaluation in the clinical set-
tings. They are acting earlier in the clinical scene, 
offered for use in different forms, as pills, drops, 
capsules, solutions. Their possibilities to act have 
been established in clinical guidelines and manuals, 
like scientific knowledge embedded in a discrete 
substance to work in distant spaces and different 
bodies. Thus, psychotropic drugs are previous due 
to the scientific procedure, and their indications 
are associated with specific usages and diagnos-
tic categories. Indeed, there exists a connection 
between psychotropic drugs and the knowledge 
infrastructure delegated into the substance, which 
has previously been associated with a diagnostic 
entity. This connection is legitimated within the 
framework of the chemical imbalance hypothesis 
(Healy, 1997, 2002). The new psychiatry produced 
by the so-called “pharmacological revolution” is 
based on the hypothesis that psychotropic drugs 
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have specific effects on behaviour or state of mind, 
modeling mental disorders as an expression of a bio-
logical brain dysfunction (Healey, 1997; Orr, 2010). 
According to this scientific model, the significances 
produced by clinical collectives are transformed in 
actions and decisions in clinical settings. Thus, the 
psychiatric substances as semiotic-material tools, 
offer the materiality and significances to make 
diagnosis. In this sense psychiatric judgement is 
not only unfolded through the psychiatrist’s skills 
and expertise, but seems to mobilize the scientific 
evidence embodied in the psychopharmacological 
substances.
As the following extract illustrates, Extract 
Nº 5:
We interview a new patient (Francisco) who ad-
mitted himself to the emergency hospital before he 
could commit a violent act against other people. He 
consumed alcohol for a long time and therefore had 
family troubles. He has been administered benzodi-
azepines for the withdrawal syndrome, antidepres-
sant and hypnotic and a serie of medicines for other 
medical problems (Field-note, 12 November 2012). 
The day after we come back to visit Fernando. After 
the interview we talk in a medical ward. Asking the 
psychiatrist for Fernando s´ diagnosis, I recognize 
that the answer depends on the patient´ s response 
to the therapeutic drug treatment: if he responds 
better to the reduction of benzodiazepines than to 
antidepressants, the answer tends to a SRAD6 rather 
than a DD7 or vice versa (Field-note, 13 November 
2012, author’s translation).
The clinical observation is meaningless in this 
situation. The important issue is which adminis-
tered psychotropic drugs related to a specific mental 
disease are more effective and produce a quicker 
recovery. There is an inversion in the diagnostic 
process, whereby the therapeutic substance acts to 
attribute meanings and validate diagnosis-making. 
Thus, diagnosis as part of articulation work to man-
age medical practices (Strauss, 1985) is enacted as 
6 Substance-Related and Addictive Disorder.
7 Depressive Disorder.
a result of the psychotropic substances translation. 
According to the concept of translation posed by 
Callon (1986), psychoactive drugs seem to propose 
the way to organize diagnosis. However, while 
translation as introduced by Callon is a unidirec-
tional process, within psychiatric diagnosis-making 
a recursive translation or feedback process occurs. 
Finally the clinical hermeneutic plays a role deter-
mining whether the diagnosis will be a SRAD or 
DD. In other words, the realization of diagnosis 
involves a process of meanings attribution where 
psychotropic drugs perform the conditions for a 
clinical objectivity. However clinical expertise sub-
sequently constitutes the obligatory passage point 
that translates the materiality and meanings of 
psychotropic drugs to carry out diagnosis.
Discussion: Psychotropic drugs 
as boundary objects
In order to account for this process, the analytical 
category of “boundary objects” is applied to explain 
the articulation of practices and knowledge support-
ed by psychotropic drugs. As has been described, 
psychotropic drugs are able to manage and solve 
uncertain situations posed by the clinic, working 
as biotechnological significance-dispositifs for the 
processing of diagnostic uncertainty. In this sense 
we establish that psychotropic drugs as boundary 
objects, provide the semiotic-material (Haraway, 
1999) assemblage of diagnosis. The expression 
semiotic-material assemblage refers to a kind of 
material structure charged with significance, from 
which psychiatric diagnosis is enacted. We use the 
term assemblage in the sense of infrastructure, as 
artifact, and as the material base of psychotropic 
drugs in the diagnosis-making process.
As Trompette and Vinck (2009) have noted, 
the original conceptualization of boundary objects 
makes reference to two analytical dimensions: 
interpretive flexibility and the incorporation of 
an invisible infrastructure. Interpretive flexibility 
refers to certain properties of boundary objects, 
such as “support of heterogeneous translations, as 
dispositif of integration of knowledge, as mediation 
in the process of coordination between experts and 
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non-experts” (Trompette & Vinck, 2009). In the 
current analysis, the interpretive flexibility of psy-
chotropic drugs supports or rather administers the 
ambiguity and uncertainty of psychiatric practices 
in the process of diagnosis-making in its own ma-
teriality. Crucial is the way in which psychotropic 
drugs as boundary objects encapsulate and manage 
a multiplicity of entities where the contradictions, 
ambiguities and uncertainties (for example among 
the diagnostic categories) are no obstacle to the ac-
tion. The actions of psychotropic drugs, with their 
expected and promised effects, bring continuity to 
clinical practices. They displace difficulties in the 
evolution of action, thus dissolving barriers estab-
lished by the clinical activities. It is the action of 
psychotropic drugs, as well as the certainties and 
promises of their effects, which allows diagnoses 
with different epistemological trajectories, such as 
OCD, schizophrenia and cognitive impairment, 
to be managed as equivalent entities in the same 
plane. Psychotropic drugs give continuity to the 
work of psychiatrists, as they face the expected and 
unexpected contingencies in the illness trajectory. 
Thus, psychotropic drugs act as boundary objects, 
the interpretive flexibility which assemble the ac-
tors, making collective work and the negotiation 
of meanings possible in the psychiatric practices 
analyzed.
In addition, the second analytical dimension 
- the invisible infrastructure - is the property that 
explains the processes of delegation and refers to the 
transport of categories, classifications and norms 
that occurs in the interaction. This dimension 
highlights the practices of scientific work that are 
often blurred, lost or hidden behind the clean and 
clear presentation of the outcomes translated into 
stabilized scientific knowledge. According to Star 
and Ruhleder (1996), the invisible infrastructure 
is the result of collective work, it is therefore a rela-
tional concept arising from practices. Considering 
psychotropic drugs as boundary objects, makes it 
possible to grasp how groups produce and man-
age information, incorporating the materiality, as 
the central mediation in knowledge management 
(Trompette & Vinck, 2009). More fundamentally, 
it enables us to visualize how psychiatric drugs as 
boundary objects support an invisible infrastruc-
ture of knowledge that materializes and mobilizes 
the scientific assemblage of biopsychiatric truth 
regimes, articulated for diagnosis-making by the 
psychotropic drugs themselves.
Conclusion
Researchers have emphasized the changes occur-
ring in clinical practices within biomedicine, result-
ing from the continuous production of biomedical 
entities, and how, in this process, diagnostic clini-
cal judgement is being transformed. These studies 
agree that the reconfiguration of clinical judgement 
in biomedicine has involved a shift in locus from 
clinical to bioclinical collectives (Bourret, 2005), 
maintaining slight differences in descriptions of 
this process. The majority of these works have been 
carried out in the field of oncology, where research 
is highly active (Rabeharisoa & Bourret, 2009). 
In the field of psychiatry, however, less attention 
has been paid to this development. Therefore, we 
would like to enrich the debate by making visible 
the peculiarities of diagnostic psychiatric judge-
ment within these biomedical transformations. In 
this domain, we claim that diagnostic judgements 
not only originate from the skills and expertise of 
psychiatrists, but are also produced by the mobiliza-
tion of scientific evidence embedded in psychophar-
macological substances. This assertion challenges 
the hegemonically established mainstream truth 
(Ibáñez, 1993).
This study also emphasizes how the use of 
psychotropic drugs connects the field of practices 
to the new bioclinical collectives. Psychotropic 
drugs as technological significance-dispositif, 
mediate the field of clinical practices with col-
lective spaces of production and regulation of 
biomedical entities. As part of this operation, 
psychotropic substances translate the psychiatric 
clinical judgement in order to carry out diagnosis, 
but the clinical judgement subsequently translates 
the materiality and significance presented by psy-
chotropic drugs. As a result, psychiatric clinical 
judgement arises from the semiotic-material as-
semblage of psychopharmacological substances. 
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Therefore, clinical hermeneutics is also a decod-
ing process, where the attributed meanings have 
previously been performed by psychotropic drugs. 
The analytical dimension of boundary objects is 
an artifact to comprehend this operation. In this 
work, psychotropic drugs as boundary objects de-
scribe a trajectory that connects and articulates 
bioclinical collectives with bodies of patients, 
psychiatrists, diagnostic categories and all sorts 
of materializations of scientific evidence. In this 
movement, diagnostic assignations are merely a 
transitional stabilization of psychotropic drugs in 
the illness trajectory. In biopsychiatry, psychotro-
pic drugs as boundary objects act as central media-
tors in knowledge management, establishing the 
semiotic-material assemblage of diagnosis.
References
Basaglia, F. (1972). La institucion negada: Informe de un 
hospital psiquiátrico. Barcelona: Barral.
Basaglia, F., & Carrino, L. (1975). Psiquiatría, antip-
siquiatría y orden manicomial. Barcelona: Barral.
Blaxter, M. (1978). Diagnosis as category and process: 
The case of alcoholism. Social Science & Medi-
cine, 12(0), 9-17. http://dx.doi.org/10.1016/0271-
7123(78)90017-2
Bourret, P. (2005). BRCA patients and clinical col-
lectives: New configurations of action in cancer 
genetic practices. Social Studies of Science, 35(1), 
51, 41-68.
Bowker, G. C., & Star, S. L. (1999). Sorting things out: 
Classification and its consequences. Cambridge, 
MA: MIT Press.
Brown, P. (1995). Naming and framing: The social con-
struction of diagnosis and illness. Journal of Health 
and Social Behavior, 35, 34-52.
Brown, P., & Zavestoski, S. (2004). Social movements 
in health: An introduction. Sociology of Health & 
Illness, 26(6), 679-694. http://dx.doi.org/10.1111
/j.0141-9889.2004.00413.
Callon, M. (1986). Algunos elementos para una soci-
ología de la traducción: la domesticación de las 
vieiras y los pescadores de la bahía de St. Brieuc. 
En J. M. Iranzo, González de la Fe, T., & J. Blanco 
(Eds.), Sociología de la ciencia y la tecnología. Ma-
drid: CIS.
Cambrosio, A., Keating, P., Schlich, T., & Weisz, G. 
(2006). Regulatory objectivity and the generation 
and management of evidence in medicine. Social 
Science Medicine, 63(1), 189-199.
Conrad, P. (1975). The discovery of hyperkinesis: Notes 
on the medicalization of deviant behavior. Social 
Problems, 23(1), 12-21.
Conrad, P. (1979). Types of medical social control. So-
ciology of Health & Illness, 1(1), 1-11. http://dx.doi.
org/10.1111/j.1467-9566.1979.tb00175.x
Conrad, P., & Schneider, J. (1980). Deviance and medi-
calization: From badness to sickness. St. Louis, MO: 
The C.V. Mosby Company.
Conrad, P. (1992). Medicalization and social control. 
Annual Review of Sociology, 18, 209-232.
Conrad, P. (2007). The medicalization of society: On the 
transformation of human conditions into treatable dis-
orders. Baltimore: Johns Hopkins University Press.
Cooper, D. (1974). Psiquiatría y antipsiquiatría. Buenos 
Aires: Paidós.
Foucault, M. (2003). Le pouvoir psychiatrique. Cours 
au Collège de France: 1973-1974. París: Seuil/Gal-
limard.
Fujimura, J. (1992). Crafting science: Standardized 
packages, boundary objects, and translation. En 
A. Pickering (Ed.), Science as practice and culture 
(pp. 168-211). University of Chicago Press.
Gardner, J., Dew, K., Stubbe, M., Dowell, T., & Macdon-
ald, L. (2011). Patchwork diagnoses: The produc-
tion of coherence, uncertainty, and manageable 
bodies. Social Science & Medicine, 73(6), 843-
850. http://dx.doi.org.are.uab.cat/10.1016/j.socs-
cimed.2010.12.010
Geertz, C. (1987). La interpretación de las culturas. Méxi-
co: Gedisa.
Goode, E. (1969). Marijuana and the politics of reality. 
Journal of Health and Social Behavior, 10(2), 83-94.
Haraway, D. (1999) Las promesas de los monstruos: una 
política regeneradora para otros inapropiados/bles. 
Política y Sociedad, 30, 121-163.
Healy, D. (1997). The antidepressant era. Cambridge MA: 
Harvard University Press.
Healy, D. (2002). The creation of psychopharmacology. 
Cambridge, MA: Harvard University Press.
Silvia Carolina Geneyro Saldombide, FranCiSCo Tirado
1830        Un i v e r s i ta s Ps yc h o l o g i c a       V.  14      No.  5       e di c ió n e s P e c i a l       2015   
Horwitz, A. V. (2011). Creating an age of depression. 
Society and Mental Health, 1(1), 41-54. http://dx.doi.
org/10.1177/2156869310393986
Ibáñez, T. (1993). La dimensión política de la psicología 
social. Revista Latinoamericana de Psicología, 25(1), 
19-34.
Jutel, A. (2008). Doctor’s orders: Diagnosis, medicalisa-
tion and the exploitation of anti-fat stigma. En J. 
Wright, & V. Harwood (Eds.), Biopolitics and the 
‘obesity epidemic’: Governing bodies. Nueva York: 
Routledge.
Jutel, A. (2009). Sociology of diagnosis: A preliminary 
review. Sociology of Health & Illness, 31(2), 278-299. 
http://dx.doi.org/10.1111/j.1467-9566.2008.01152.x
Jutel, A., & Nettleton, S. (2011). Towards a sociology 
of diagnosis: Reflections and opportunities. Social 
Science & Medicine, 73(6), 793-800. http://dx.doi.
org.are.uab.cat/10.1016/j.socscimed.2011.07.014
Keating, P., & Cambrosio, A. (2003). Biomedical plat-
forms: Realigning the normal and the pathological in 
late-twentieth-century medicine. Cambridge: MIT 
Press.
Knoblauch, H. (2005). Focused ethnography. Forum 
Qualitative Sozialforschung, 6(3) Art. 44. Recu-
erado de http://nbnresolving. de/urn:nbn:de:0114-
fqs0503440.
Latour, B. (1998). La tecnología es la sociedad hecha pa-
ra que dure. En M. Doménech, & F. Tirado (Eds.), 
Sociología simétrica. Ensayos sobre ciencia tecnología 
y sociedad (pp.109-142). Barcelona: Gedisa.
Latour, B. (2001). La esperanza de pandora: Ensayos sobre 
la realidad de los estudios de la ciencia. Barcelona: 
Gedisa.
Leder, D. (2016). The distressed body. Rethinking ill-
ness, imprisonment and healing. Chicago: The 
University of Chicago Press.
Lillrank, A. (2003). Back pain and the resolution of 
diagnostic uncertainty in illness narratives. Social 
Science & Medicine, 57(6), 1045-1054. http://dx.doi.
org.are.uab.cat/10.1016/S0277-9536(02)00479-3
Mol, A. (2002). The body multiple: Ontology in medical 
practice. Durham, North Carolina: Duke Univer-
sity Press.
Moncrieff, J. (2010). Psychiatric diagnosis as a political 
device. Social Theory & Health, 8(4) 370-382.
Orr, J. (2010). Biopsychiatry and the informatics of diag-
nosis. En A. Clarke, L. Mamo, J. Fosket, J. Fishman 
& J. Shim (Eds.), Biomedicalization. United States 
of America: Duke University Press.
Rabeharisoa, V., & Bourret, P. (2009). Staging and 
weighting evidence in biomedicine: Comparing 
clinical practices in cancer genetics and psychiatric 
genetics. Social Studies of Science, 39(5), 691-715. 
http://dx.doi.org.10.1177/0306312709103501
Ruiz Olabuénaga, J. (2003). Metodología de la investig-
ación cualitativa. Bilbao: Universidad de Deusto.
Sacket, D., Rosenberg, W., Gray, J., Haynes, B., Richard-
son, W. (1992). Evidence-based-medicine: What 
it is and what it isn’t. British Medical Journal, 312, 
71-72.
Scott, W. (1990). PTSD in DSM III: A case in the 
politics of diagnosis and disease. Social Problems, 
37(3) 37, 294-310.
Scott, W. (2006) The medicalisation of shyness: From 
social misfits to social fitness, Sociology of Health 
and Illness, 28(2), 133-53.
Singh, I. (2011). A disorder of anger and aggression: 
Children’s perspectives on attention deficit/hy-
peractivity disorder in the UK. Social Science & 
Medicine, 73(6), 889-896. http://dx.doi.org.are.uab.
cat/10.1016/j.socscimed.2011.03.049
Star, S. L., & Griesemer, J. R. (1989). Institutional ecol-
ogy, ‘translations’ and boundary objects: Amateurs 
and professionals in Berkeley’s Museum of Verte-
brate Zoology, 1907-1939. Social Studies of Science, 
19(3), 387-420.
Star, S. L., & Ruhleder, K. (1996). Steps toward an ecol-
ogy of infrastructure: Design and access for large 
information spaces. Information Systems Research, 
7(1), 111-134.
Star, S. L. (2010). This is not a boundary object: Reflec-
tions on the origin of a concept. Science, Technology 
& Human Values, 35(5), 601-617.
Strauss, A. (1985). Continual permutations of actions. 
New York: Aldine de Gruyter.
Szasz, T. (2007). The Medicalization of Everyday Life. 
Selected Essays. Syracuse NY: Syracuse University 
Press.
Trompette, P., & Vinck, D. (2009). Regreso sobre la 
noción de objeto frontera. Revue d a´nthropologie 
Des Connaissances, 3(1), 4-26.
The STabilizaTion of PSychiaTric DiagnoSiS: PSychoTroPic DrugS aS bounDary objecTS
   Un i v e r s i ta s Ps yc h o l o g i c a       V.  14      No.  5       e di c ió n e s P e c i a l       2015     1831 
Trundle, C. (2011). Biopolitical endpoints: Diagnosing 
a deserving british nuclear test veteran. Social Sci-
ence & Medicine, 73(6), 882-888. http://dx.doi.org.
are.uab.cat/10.1016/j.socscimed.2011.05.034
Zola, I. K. (1972). Medicine as an institution of so-
cial control. The Sociological Review, 20(4), 487-
504. http://dx.doi.org/10.1111/j.1467-954X.1972.
tb00220.x

